tiprankstipranks
Trending News
More News >

Matt Larew Profile - William Blair Analyst

18 Followers
tipranks
Matt Larew

Matt Larew
William Blair

Wall Street Analyst
#8,505 out of 10,113 Wall Street Analysts
#27,758 out of 42,320 experts

Success Rate

46%
36 out of 78 ratings made a profit

Average Return

-3.50%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Matt Larew's trades since 2017 and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -3.5% per rating.

Stock Rating Distribution

134Ratings
63.43% Buy
32.09% Hold
4.48% Sell
Distribution of Matt Larew's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Ginkgo Bioworks Holdings, Inc.
(DNA)
Rating:Sell
Date:May 10, 2024 - May 10, 2025
Return:+74.50%
The most profitable rating made by Matt Larew

Matt Larew's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Encompass Health
Nov 21, 2017
Buy
Initiated
1Ratings
100%
+48.50%
LPNT
LifePoint Health
Jul 23, 2018
Hold
Downgraded
1Ratings
0.00%
Labcorp Holdings
Dec 03, 2018
Buy
Reiterated
1Ratings
100%
+15.00%
DaVita
Sep 11, 2019
Hold
Downgraded
4Ratings
50%
-9.05%
ZY
Zymergen
Aug 04, 2021
Hold
Downgraded
2Ratings
0%
-78.20%
InnovAge Holding
Sep 22, 2021
Hold
Downgraded
2Ratings
0%
-63.50%
LHCG
LHC Group
Mar 29, 2022
Hold
Downgraded
3Ratings
100%
+47.30%
SYNH
Syneos Health
Aug 03, 2022
Hold
Downgraded
1Ratings
0.00%
Signify NV
Aug 22, 2022
Buy
Reiterated
1Ratings
0%
-7.50%
SGFY
Signify Health
Sep 06, 2022
Hold
Downgraded
2Ratings
0%
-44.70%
List of latest recommendations made by Matt Larew. Click to expand and see Matt Larew's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Matt Larew activity FAQ

What is the performance of Matt Larew's recommendations?
The percentage of profitable recommendations made by Matt Larew is 46%, and the average return per transaction is -3.50%.
    What stocks does Matt Larew cover?
    Matt Larew mostly covers MRVI ,MASS ,DNA stocks.
      What was Matt Larew's most profitable rating?
      Matt Larew’s most profitable ratings was a sell on DNA stock on May 10, 2024 - May 10, 2025. The return on the trade was +74.50%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here